Quantcast

Latest Attention-deficit hyperactivity disorder management Stories

79c387277e98069442b4eadafab9d1711
2011-04-20 12:45:00

According to a new study from Sweden, the earlier babies are born, the more likely they are to later get a prescription for ADHD medication. Researchers said that they found that babies born as little as three weeks before their due dates had an elevated risk for attention deficit hyperactivity disorder (ADHD). The authors said that the findings suggest that mothers considering scheduling cesarean births a few weeks early reconsider and deliver as close to term as possible. People with ADHD...

2011-03-01 14:02:47

A new study in the March 1 issue of the journal SLEEP indicates that the ability of children with attention deficit hyperactivity disorder to remain vigilant and attentive deteriorated significantly after losing less than one hour of nightly sleep for a week.  The study suggests that even moderate reductions in sleep duration can affect neurobehavioral functioning, which may have a negative impact on the academic performance of children with ADHD. Results of multivariate analyses of...

2011-02-28 22:32:38

Faced with the risk of developing side effects, even ones as mild as fatigue, nausea and fuzzy thinking, many older patients are willing to forego medications that provide only average benefit in preventing heart attack, according to a report by Yale School of Medicine researchers. "These patients are willing to take medications for cardiovascular disease prevention, but only if they are not linked to what are generally considered to be acceptable side effects," said first author Terri R....

2011-02-28 08:00:00

PHILADELPHIA, Feb. 28, 2011 /PRNewswire/ -- Shire plc, (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, today announced that the US Food and Drug Administration (FDA) approved the use of once-daily INTUNIV® (guanfacine) Extended-Release Tablets as adjunctive therapy to stimulants for the treatment of attention deficit hyperactivity disorder (ADHD) in children and adolescents ages 6 to 17 as part of a total treatment program. The approval is based...

2011-02-28 07:59:00

PHILADELPHIA, February 28, 2011 /PRNewswire-FirstCall/ -- Shire plc, (http://www.shire.com/shireplc/en/home ) (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced that the US Food and Drug Administration (FDA) approved the use of once-daily INTUNIV(R) (guanfacine) Extended-Release Tablets (http://www.intuniv.com/) as adjunctive therapy to stimulants for the treatment of attention deficit hyperactivity disorder (ADHD) in children and adolescents ages 6...

9c5a5869e0b8072efe5abfddb8ef9d691
2011-02-15 13:06:10

Measurements of hand movement control may help determine the severity of attention deficit hyperactivity disorder (ADHD) in children, according to joint studies published in the February 15, 2011, print issue of Neurology®, the medical journal of the American Academy of Neurology. ADHD is a brain disorder characterized by impulsiveness, hyperactivity, such as not being able to sit still, and inattention or difficulty staying focused. The studies were led by Stewart H....

2011-02-10 08:29:00

(Ivanhoe Newswire) -- A special restricted diet should be part of the standard of care for all children with attention-deficit hyperactivity disorder (ADHD), according to this study. Previous work established ADHD might be an allergic or non-allergic hypersensitivity disorder in some children, triggered by any types of food that can cause allergic reactions. In this new study children aged 4 to 8 years previously diagnosed with ADHD took part in this randomized controlled trial, in which 50...

2011-02-09 17:46:00

EL CAJON, Calif., Feb. 9, 2011 /PRNewswire/ -- On January 26, 2011, it was reported that 13 University of Iowa football players were affected so severely by rhabdomyolysis that they were hospitalized. Occurrences of rhabdomyolysis--muscle breakdown--are so rare that it suggests an additional causal factor, such as a drug. Drugs known as 'statins,' widely used to lower cholesterol, are known in rare cases to cause rhabdomyolysis. It seems more likely, however, that amphetamines,...

2011-01-10 07:20:00

FLORHAM PARK, N.J., Jan. 10, 2011 /PRNewswire/ -- Shionogi Inc., the U.S.-based group company of Shionogi & Co., Ltd., today announced a true milestone as it marks the first commercial availability for the non-central nervous system stimulant medication KAPVAY(TM), an extended-release oral formulation of clonidine for Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents. KAPVAY(TM) is the first and only FDA-approved ADHD treatment indicated for use as add-on...

2010-12-20 09:30:00

PHILADELPHIA, Dec. 20, 2010 /PRNewswire-USNewswire/ -- For doctors and parents to jointly decide how to attack pediatric conditions, such as attention-deficit/hyperactivity disorder (ADHD), practical barriers to recommended health treatments need to be overcome, according to a study by The Children's Hospital of Philadelphia. In considering their options, parents preferred their physicians to offer an unbiased presentation of all available treatments. The study, published online today...


Word of the Day
vermicular
  • Like a worm in form or movement; vermiform; tortuous or sinuous; also, writhing or wriggling.
  • Like the track or trace of a worm; appearing as if worm-eaten; vermiculate.
  • Marked with fine, close-set, wavy or tortuous lines of color; vermiculated.
  • A form of rusticated masonry which is so wrought as to appear thickly indented with worm-tracks.
This word ultimately comes from the Latin 'vermis,' worm.
Related